Biotech

Apiam Animal Health Limited (ASX:AHX) Q1 FY24 Performance Update

🕔10/19/2023 8:47:35 AM

Apiam Animal Health Limited (ASX:AHX) today announced an update on the Company's performance for the quarter ended 30 September 2023 (Q1 FY24).

Read Full Article

Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome

🕔10/18/2023 12:51:31 PM

Anatara Lifesciences (ASX:ANR) is pleased to invite shareholders, investors and interested parties to an online Webinar on the Company's Stage 1 Irritable Bowel Syndrome (IBS) clinical trial results, hosted by Chair, Dr. David Brookes.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) International Webinar and Q&A

🕔9/29/2023 3:04:01 PM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Reimbursement Price & Aus Regulatory Decision

🕔9/29/2023 9:19:49 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.

Read Full Article

Ellis Martin Report with TONIX Pharmaceuticals Holding Corp.'s (NASDAQ:TNXP) Dr Seth Lederman

🕔9/18/2023 9:39:51 AM

Join Ellis Martin for a compelling interview with Dr. Seth Lederman. He's an MD and the CEO of TONIX Pharmaceuticals Holding Corp. (NASDAQ:TNXP).

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented at Global Conference

🕔9/8/2023 8:24:21 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.

Read Full Article

Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Platform Technology Secures Patent in Japan

🕔9/4/2023 8:12:36 AM

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.

Read Full Article